Robbins Arroyo LLP Is Investigating the Officers and Directors of Alexion Pharmaceuticals, Inc. (ALXN) on Behalf of
Shareholders
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Alexion Pharmaceuticals, Inc. (NasdaqGS: ALXN) breached
their fiduciary duties to shareholders. Alexion, a biopharmaceutical company, develops and commercializes life-transforming
therapeutic products.
View this press release on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/shareholders-rights-blog/alexion-pharmaceuticals-inc
Alexion Under Investigation By the U.S. Health Inspector General
Alexion is under investigation by the U.S. Department of Health and Human Services' Office of Inspector General related to a
probe by the U.S. Attorney's Office for the District of Massachusetts and the Department of Justice concerning the company's
support for charities that aid Medicare patients. A Bloomberg investigation in May found a widespread culture of aggressive sales
at Alexion aimed at seeking new potential customers and keeping patients on Alexion's main drug, Soliris. Alexion also disclosed
that it is under investigation by the U.S. Securities and Exchange Commission and Department of Justice for issues related to the
Foreign Corrupt Practices Act in Brazil.
Alexion Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Leonid
Kandinov at (800) 350-6003, LKandinov@robbinsarroyo.com, or via the
shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional
investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion
of value for themselves and the companies in which they have invested.
Attorney Advertising. Past results do not guarantee a similar outcome.
Robbins Arroyo LLP
Leonid Kandinov
(619) 525-3990 or Toll Free (800) 350-6003
LKandinov@robbinsarroyo.com
www.robbinsarroyo.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170719006151/en/